Dexamethasone Patent Expiration
Dexamethasone is Used for treating eye conditions such as diabetic macular edema, macular edema, non-infectious uveitis, and uveitis by delivering an ocular implant. It was first introduced by Merck And Co Inc
Dexamethasone Patents
Given below is the list of patents protecting Dexamethasone, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Dexycu Kit | US11097061 | Systems, kits and methods for loading and delivering a small volume dose from a syringe | Jun 23, 2039 | Eyepoint Pharms |
Hemady | US10537585 | Compositions comprising dexamethasone | Dec 18, 2037 | Dexcel |
Hemady | US11304961 | Compositions comprising dexamethasone | Dec 18, 2037 | Dexcel |
Dextenza | US11458041 | Punctal plug and bioadhesives | Nov 16, 2037 | Ocular Therapeutix |
Dexycu Kit | US10022502 | Dose guides for injection syringe | Jun 22, 2034 | Eyepoint Pharms |
Dexycu Kit | US10028965 | Use of sustained release dexamethasone in post-cataract surgery inflammation | May 23, 2034 | Eyepoint Pharms |
Dexycu Kit | US10159683 | Use of sustained release dexamethasone in post-cataract surgery inflammation | May 23, 2034 | Eyepoint Pharms |
Dexycu Kit | US10799642 | Dose guides for injection syringe | May 11, 2032 | Eyepoint Pharms |
Dextenza | US8409606 | Drug delivery through hydrogel plugs | May 14, 2030 | Ocular Therapeutix |
Dextenza | US8563027 | Drug delivery through hydrogel plugs | Feb 12, 2030 | Ocular Therapeutix |
Dextenza | US9254267 | Composite hydrogel drug delivery systems |
Sep 11, 2024
(Expired) | Ocular Therapeutix |
Ozurdex | US6899717 | Methods and apparatus for delivery of ocular implants |
Nov 01, 2023
(Expired) | Abbvie |
Dexycu Kit | US6960346 | Vehicles for delivery of biologically active substances |
Jul 03, 2023
(Expired) | Eyepoint Pharms |
Ozurdex | US10076526 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
Ozurdex | US10702539 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
Ozurdex | US8034366 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
Ozurdex | US8034370 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
Ozurdex | US8506987 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
Ozurdex | US9192511 | Ocular implant made by a double extrusion process |
Jan 09, 2023
(Expired) | Abbvie |
Dexycu Kit | US7560120 | Vehicles for delivery of biologically active substances |
Sep 05, 2022
(Expired) | Eyepoint Pharms |
Ozurdex | US7767223 | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use |
Nov 28, 2021
(Expired) | Abbvie |
Ozurdex | US6726918 | Methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US7033605 | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US8043628 | Methods for reducing edema |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US8063031 | Implants and methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US8088407 | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US9012437 | Implants and methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US9283178 | Methods for treating edema in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US9592242 | Methods for treating edema in the eye and intraocular implants for use therefor |
Oct 20, 2020
(Expired) | Abbvie |
Ozurdex | US9775849 | Implants and methods for treating inflammation-mediated conditions of the eye |
Oct 20, 2020
(Expired) | Abbvie |
Dexamethasone's Family Patents
Explore Our Curated Drug Screens
Dexamethasone Generic API Manufacturers
Several generic applications have been filed for Dexamethasone. The first generic version for Dexamethasone was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Corepharma Llc and was approved on Sep 17, 2024.
Given below is the list of companies who have filed for Dexamethasone generic, along with the locations of their manufacturing plants worldwide..
1. ABRAXEOLUS
Abraxeolus Consulting Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Abraxeolus.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.25MG | tablet | Discontinued | ORAL | N/A | Apr 28, 1983 |
2. ALLERGAN HERBERT
Allergan Herbert Div Allergan Inc has filed for 1 generic for Dexamethasone. This 0.01% **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name AEROSEB-DEX. Given below are the details of the strengths of this generic introduced by Allergan Herbert.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | aerosol | Discontinued | TOPICAL | N/A | Approved Prior to Jan 1, 1982 |
3. ALPHARMA US PHARMS
Alpharma Us Pharmaceuticals Division has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Alpharma Us Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.5MG/5ML | elixir | Discontinued | ORAL | N/A | Oct 10, 1986 |
4. ALVOGEN
Alvogen Inc has filed for 4 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Alvogen.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.5MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
0.75MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
4MG | tablet | Prescription | ORAL | AB | Apr 28, 1983 |
6MG | tablet | Prescription | ORAL | AB | Nov 28, 1983 |
Manufacturing Plant Locations New
Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
5. AMNEAL
Amneal Eu Ltd has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Amneal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
6MG | tablet | Prescription | ORAL | AB | Oct 14, 2021 |
4MG | tablet | Prescription | ORAL | AB | Oct 14, 2021 |
2MG | tablet | Prescription | ORAL | AB | Sep 8, 2022 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||
India |
|
6. APOTEX
Apotex Inc has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
1.5MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
1MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
0.75MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
6MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
4MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
0.5MG | tablet | Prescription | ORAL | AB | Aug 23, 2023 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||
Canada |
| |||||||||||||
India |
|
7. BAUSCH
Bausch Health Americas Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Bausch.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Discontinued | ORAL | N/A | Aug 15, 2008 |
Manufacturing Plant Locations New
Bausch's manufacturing plants are situated in 2 countries - United States, Canada. Given below are the details of these plant locations as well as the firm names of Bausch as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||||||||||
Canada |
|
8. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Bionpharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
4MG | tablet | Prescription | ORAL | AB | Apr 19, 2023 |
6MG | tablet | Prescription | ORAL | AB | Apr 19, 2023 |
2MG | tablet | Prescription | ORAL | AB | Apr 26, 2023 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
9. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.5MG/5ML | elixir | Prescription | ORAL | AA | May 11, 2011 |
10. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
11. COREPHARMA
Corepharma Llc has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Corepharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Prescription | ORAL | AB | Sep 17, 2024 |
6MG | tablet | Prescription | ORAL | AB | Sep 17, 2024 |
4MG | tablet | Prescription | ORAL | AB | Sep 17, 2024 |
0.5MG | tablet | Prescription | ORAL | AB | Sep 17, 2024 |
2MG | tablet | Prescription | ORAL | AB | Sep 17, 2024 |
0.75MG | tablet | Prescription | ORAL | AB | Sep 17, 2024 |
1MG | tablet | Prescription | ORAL | AB | Sep 17, 2024 |
Manufacturing Plant Locations New
Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
12. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 9 different strengths of generic version for Dexamethasone. Out of these 1mg/ml version comes by the name DEXAMETHASONE INTENSOL. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
0.5MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
4MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
0.75MG
(reference listed drug) | tablet | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
2MG
(reference standard) (reference listed drug) | tablet | Prescription | ORAL | AB | Aug 26, 1982 |
0.5MG/5ML
(reference standard) (reference listed drug) | solution | Prescription | ORAL | N/A | Sep 1, 1983 |
1MG/ML
(reference standard) | concentrate | Prescription | ORAL | N/A | Sep 1, 1983 |
1MG
(reference standard) (reference listed drug) | tablet | Prescription | ORAL | AB | Sep 15, 1983 |
6MG
(reference standard) (reference listed drug) | tablet | Prescription | ORAL | AB | Sep 15, 1983 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
13. IMPAX LABS
Impax Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Impax Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
14. KANCHAN HLTHCARE
Kanchan Healthcare Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Kanchan Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.5MG/5ML
(reference standard) | elixir | Prescription | ORAL | AA | Approved Prior to Jan 1, 1982 |
15. KEY THERAP
Key Therapeutics Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Key Therap.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Discontinued | ORAL | N/A | Apr 28, 1983 |
16. LARKEN LABS INC
Larken Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Larken Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Prescription | ORAL | AB | Jul 17, 2017 |
17. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 6 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Prescription | ORAL | AB | Aug 8, 2022 |
4MG | tablet | Prescription | ORAL | AB | Aug 8, 2022 |
6MG | tablet | Prescription | ORAL | AB | Aug 8, 2022 |
2MG | tablet | Prescription | ORAL | AB | May 9, 2023 |
0.75MG | tablet | Prescription | ORAL | AB | Oct 5, 2023 |
0.5MG | tablet | Prescription | ORAL | AB | Oct 5, 2023 |
Manufacturing Plant Locations New
Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
18. PAR PHARM
Par Pharmaceutical Inc has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Par Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.5MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
0.75MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
4MG | tablet | Prescription | ORAL | BP | Apr 28, 1983 |
Manufacturing Plant Locations New
Par Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Par Pharm as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
|
19. PHARMOBEDIENT CNSLTG
Pharmobedient Consulting has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.5MG/5ML
(reference listed drug) | elixir | Discontinued | ORAL | N/A | Jul 27, 1983 |
20. PHOENIX LABS NY
Phoenix Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Phoenix Labs Ny.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
21. PRASCO
Prasco Llc Dba Prasco Laboratories has filed for 2 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Prasco.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
4MG | tablet | Prescription | ORAL | AB | Apr 20, 2022 |
Manufacturing Plant Locations New
Prasco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Prasco as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
22. PVT FORM
Private Formulations Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pvt Form.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
23. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.5MG/5ML | elixir | Prescription | ORAL | AA | Jul 12, 2011 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
24. ROXANE
Roxane Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Roxane.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.25MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
25. SOLVAY
Solvay Pharmaceuticals has filed for 4 different strengths of generic version for Dexamethasone. Out of these 1.5mg version comes by the name DEXONE 1.5, 0.5mg version comes by the name DEXONE 0.5, 4mg version comes by the name DEXONE 4, 0.75mg version comes by the name DEXONE 0.75. Given below are the details of the strengths of this generic introduced by Solvay.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
4MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
Manufacturing Plant Locations New
Solvay's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Solvay as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
|
26. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.25MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
27. UPSHER SMITH
Upsher Smith Laboratories Inc has filed for 2 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Upsher Smith.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
Manufacturing Plant Locations New
Upsher Smith's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Upsher Smith as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
28. WATSON LABS
Watson Laboratories Inc has filed for 5 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Watson Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
1.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.25MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.5MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
0.1% | suspension/drops | Discontinued | OPHTHALMIC | N/A | May 9, 1989 |
29. WHITEWORTH TOWN PLSN
Whiteworth Towne Paulsen Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Whiteworth Town Plsn.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.75MG | tablet | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
30. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
6MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
4MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
1.5MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
0.75MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
0.5MG | tablet | Prescription | ORAL | AB | Feb 7, 2024 |
1MG | tablet | Prescription | ORAL | AB | May 9, 2024 |
Manufacturing Plant Locations New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|